17.01.2008
opracowanie na podstawie: Zoledronic acid and clinical fractures and mortality after hip fracture
K.W. Lyles, C.S. Colón-Emeric, J.S. Magaziner, J.D. Adachi, C.F. Pieper, C. Mautalen, L. Hyldstrup, C. Recknor, L. Nordsletten, K.A. Moore, C. Lavecchia, J. Zhang, P. Mesenbrink, P.K. Hodgson, K. Abrams, J.J. Orloff, Z. Horowitz, E.F. Eriksen, S. Boonen; for the HORIZON Recurrent Fracture Trial
The New England Journal of Medicine, 2007; 357: 1799–1809